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The paper quantitatively analyses the employment effects of biotechnology in Ger-
many. In 2000, a total of 614,000 employees were influenced by this technology of 
which biotechnology had a high relevance for maintaining competitiveness of 
around 220,000 jobs. In this high impact cluster the number of jobs increases to a 
range of 330,000 to 677,000 jobs in the year 2010 which equals to a maximum of 
approximately 1.7 % of all employees in Germany. Additional spill-over effects of 
biotechnology will range between 657,000 and more than 1 million jobs in the year 
2010, depending mainly on diffusion rates of biotechnology. 
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Employment in biotechnology in Germany 
 
Due to its key technology character, significant importance in the innovation proc-
ess and for maintaining competitiveness of German companies in different eco-
nomic fields specific interest is attributed to modern biotechnology (Ghislaba et al. 
1990, BMBF 2000). In addition to the pharmaceutical and chemical industry, bio-
technology influences in particular agriculture, food processing, environmental 
technologies as well as manufacturers of laboratory equipment. The present and 
future direct and indirect employment potentials of modern biotechnology in Ger-
many were analysed and quantified in a study which was financially supported by 
the German Ministry of Economic Affairs and Technology (Menrad et al. 2003). 
 
Figure 1: Basic concept of analysing the employment effects of biotechnology  
 






For analysing the employment effects of biotechnology in Germany a mix of differ-
ent methods was applied. The present employment effects of biotechnology in in-
dustry were investigated by identifying those groups in the production statistics that 
are influenced by biotechnology and by relating production volumes to the number 
of jobs (Menrad et al. 2003). In addition, available studies, in particular dealing 
with employment in research organisations and biotech firms (Hetmaier et al. 1995, 
Gießler et al. 2000, BMBF 2002) as well as information from industrial associations 
were evaluated (BDP 2002). Expert interviews were used in order to obtain infor-
mation on substitution pressure due to modern biotechnology in the various indus-
trial sectors as well as information on biotechnology effects on competitiveness. 
Employment induced by biotechnology in upstream industries was assessed using 
an input-output model (Menrad et al. 2003). 
 
For assessing future employment effects of biotechnology until 2010 a simulation 
model based on a systems dynamics approach was developed that allows to calcu-
late the job situation in the various areas affected by biotechnology and also to ob-
tain information on new employment generated and retirement. Three different sce-
narios of the diffusion of biotechnology were calculated (Menrad et al. 2003). In a 
first trend scenario it was assumed that diffusion of biotechnology proceeded at the 
same speed as during the last years. In addition, a fast diffusion scenario and a re-
tarded diffusion scenario reflected different adoption rates of modern biotechnology 
by the various sectors. In all three scenarios two versions of supply with university 
graduates were employed: a restricted version and an open approach. In a final step 
the results of the three scenarios are combined in two clusters which take the differ-
ing degree of the impacts of modern biotechnology on the competitiveness of the 
affected jobs into account (Menrad et al. 2003). 
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Employment effect of biotechnology in 2000 
 
Direct effects have to be distinguished from indirect effects when analysing the em-
ployment potentials of modern biotechnology. Direct effects occur in particular in 
universities and non-university research institutions, small and medium-sized spe-
cialised biotechnology companies, bioinstrument and -supplies manufacturers as 
well as plant-breeding companies, while indirect effects are based on the use of bio-
technological knowledge, methods, technologies and products in application indus-
tries (figure 1). In 2000 around 69,500 employees in Germany were directly af-
fected by modern biotechnology (table 1). Of these around one half (almost 
36,000 employees) were located at universities or non-university research institu-
tions. Around 33,500 employees were influenced by modern biotechnology in in-
dustrial companies of which almost 22,500 were situated in bioinstruments and -
supplies companies. In contrast, the direct employment impacts in small and me-
dium-sized biotechnology companies were rather limited with around 
10,100  employees in the year 2000. In plant-breeding companies around 
2,900 employees were influenced by modern biotechnology in this year. 
 
In upstream industries around 36,000 employees were depending on those segments 
which are directly influenced by modern biotechnology (table 1). With 
18,200 employees around half of these employees was related to bioinstruments and 
-supplies manufacturers. In contrast, university institutes and non-university re-
search institutions, which are influenced by modern biotechnology, as well as small 
and medium-sized biotechnology companies did not induce high employment ef-
fects in the input industries with together around 15,000 employees, which is caused 
by the high value-added intensity in these two fields. 
 
In the year 2000 additional 167,000 employees were indirectly influenced by the 
use of modern biotechnological methods, technologies and products in Germany 
(table 1). More than three quarters of these employees were working in the food-
processing industry in which the proportion of the total costs or the total value-6 
 
added which is influenced by modern biotechnology, is often relatively limited. In 
the other economic fields which are indirectly influenced by modern biotechnology, 
the number of affected employees was around one tenth of those in the food-
processing industry. In 2000 the respective figures of the pharmaceutical industry 
were around 13,000 employees followed by the (fine-)chemical industry with al-
most 11,300  employees and environmental biotechnology with almost 
11,200 employees. Due to the de-facto moratorium which prevents market approval 
of genetically modified organisms in the EU, it is assumed that agriculture in Ger-
many is currently not concerned with biotechnological methods, techniques or 
products. 
 
The employment effects in the upstream industries of those economic sectors which 
are indirectly influenced by modern biotechnology are significantly higher than 
those of the segments directly influenced by this technology. Within the four indi-
rectly influenced application fields around 341,000 employees could be connected 
to the use of modern biotechnological methods, techniques and products in the input 
industries in the year 2000 (table 1). This figure was also strongly shaped by the 
food-processing industry which contributed around 301,000 employees in its input 
industries. So the number of affected employees in the upstream industries was sig-
nificantly higher than the employment effects induced by modern biotechnology in 
the food-processing industry itself, what can be explained by the high input inten-
sity of the food-processing industry as well as the labour intensity above average in 
the upstream industries of food-processing (e.  g. in agriculture). With around 
18,800 employees in its upstream industries the chemical industry showed a high 
input intensity in 2000 as well. In contrast, the employment effects which were in-
duced by the pharmaceutical industry and environmental biotechnology in its up-
stream industries were smaller than the number of employees which were influ-
enced by modern biotechnology in these two economic fields. 
 7 
 
Including the employment effects on the upstream industries the total employment 
potential of biotechnology in the year 2000 can be estimated to about 614,000 jobs 
(table 1). 
 
Table 1: Employment effects of biotechnology in Germany in 2000 
Segment  Number of employees 





35,979 11,700 47,679 
Biotech  SMEs  10,103 3,300 13,403 
Bioinstrument  suppliers  20,470 18,200 38,670 
Plant breeding companies  2,964  2,900  5,864 
Total sum direct effects  69,516 36,100  105,616 
Pharmaceuticals    13,046 11,300 24,346 
Fine  chemicals  11,274 18,800 30,074 
Environmental  biotech  11,189 9,900 21,089 
Food  processing  131,376 301,500 432,876 
Total sum indirect ef-
fects 
166,884 341,500 508,384 
Total  effects  236,400 377,600 614,000 
High relevance of bio-
technology for main-
taining competitiveness 
   220,682 
Source: Menrad et al. 2003 
 
With the exception of the food-processing industries all economic fields which are 
influenced by modern biotechnology can be regarded as very knowledge intensive. 
This is clearly shown by the high percentages of employees with an academic de-
gree or a master craftsman certificate. In addition, more than 6 % of all employees 8 
 
are entrusted with R&D activities which again indicates a high research intensity 
(Menrad et al. 2003). This is in particular true for bioinstruments and -supplies 
manufacturers as well as the pharmaceutical industry. 
 
In addition to analysing the gross effects of biotechnology in the various sectors, we 
also investigated to which extent competitiveness of the different sectors was influ-
enced by biotechnology and whether biotechnology created new jobs or rather con-
tributed to the substitution of existing traditional jobs. In the pharmaceutical indus-
try there is a strong effect of biotechnology on competitiveness. Biotechnology 
leads mainly to new products, its contribution to substitution of traditional products 
is rather low. Also in the chemical industry a strong competitive effect of biotech-
nology could be detected. In this sector biotechnology is mainly used in the context 
of the introduction of new products or processes. In environmental biotechnology 
the competitiveness of about two thirds of all jobs is affected by biotechnology in 
particular in waste-water treatment. In the food industry the influence of biotech-
nology on the competitiveness of the sector has been rather limited so far. The main 
contribution of biotechnology has been in the substitution of traditional products. 
Altogether, modern biotechnological methods, approaches and products had a high 
relevance for maintaining competitiveness of around 220,000 jobs in Germany in 
2000 (table 1).  
 
Employment effects of biotechnology until 2010 
 
For estimating the future employment effects of modern biotechnology in Germany, 
three different scenarios were calculated which simulate differing diffusion rates of 
biotechnology in application industries. In a “trend scenario” it was assumed that 
diffusion of biotechnology proceeded at the same speed as during the last ten years. 
In such a scenario the number of employees directly influenced by modern biotech-
nology increased to around 136,500 persons (including the input industries) until 
2010 (figure 2). In comparison to the year 2000 the number of employees increases 
in particular in small and medium-sized specialised biotech companies as well as 9 
 
bioinstruments and –supplies manufacturers while in contrast the number of jobs 
related to universities and other research institutions is shrinking to a small extent 
(table 1, figure 2).  
 
Figure 2: Development of number of employees in directly influenced segments 
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Source: Own investigations 
 
It can be expected that the number of jobs which are indirectly influenced by mod-
ern biotechnology in application industries will significantly increase between 2000 
and 2010 (figure 3). This relates in particular to the pharmaceutical industry in 
which the number of employees affected by this technology can more than double 
to around 63,600 persons until 2010. A high absolute growth of this figure can be 
expected for the food processing industry as well, which is highly influenced by the 
effects in food processing input industries (figure 3). In contrast, only a very mod-
erate job growth induced by the use of modern biotechnology can be expected in the 
(fine) chemicals industry and in environmental biotechnology until 2010. When 
simulating the employment effects of biotechnology in Germany, it was assumed 10 
 
that the still existing de facto moratorium for genetically modified plants in the EU 
will be lifted until 2005 so that the cultivation of such plants will be allowed in the 
EU member states in subsequent years. Assuming a adoption rate of genetically 
modified plants in Germany which was observed in the USA and Canada in recent 
years this could lead to around 178,000 persons which might be influenced in the 
agricultural field by modern biotechnology in 2010 in Germany (figure 3). 
 
Figure 3: Development of number of employees in indirectly influenced segments 









































Source: Own investigations 
 
The extent of employment effects of biotechnology until 2010 is highly influenced 
by the speed of diffusion of this technology in additional application fields. This is 
illustrated in figure 4 in which is shown that around 990,000 jobs are affected by 
modern biotechnology in Germany in 2010 assuming a retarded diffusion of this 
technology (i. e. assuming half of the diffusion rate of modern biotechnology, 
which was observed in its application industries in recent years). Taking into ac-
count a rapid diffusion of biotechnological products, methods and approaches (i. e. 11 
 
doubling the diffusion rate of modern biotechnology, which was observed in its 
application industries in recent years), more than 1.7 million employees can be con-
cerned with this technology in 2010. Very differing employment effects of biotech-
nology can be observed in the food processing and pharmaceutical industry as well 
as the agricultural sector (figure4). In this sense the absorptive capabilities of the 
concerned companies form a key factor for the further diffusion of new biotechno-
logical methods, approaches and products and hence for its future employment ef-
fects. On the other hand, the already existing influence of biotechnology on very 
differing industrial branches indicates that this technology can be regarded as one of 
the future key technologies with significant cross-sectional characteristics.  
 
Figure 4: Influence of a differing speed of biotechnology diffusion on its employ-











































































Source: Own investigations 
 
Simulations for assessing the future development of the biotechnology employment 
potential reveal that the supply of university graduates until 2010 does not limit the 
development of those parts of the pharmaceutical and chemical industry, the envi-12 
 
ronmental industry, the food industry and agriculture that are affected by biotech-
nology. In contrast, the development of those sectors that are directly influenced by 
biotechnology is depending considerably on the supply of university graduates. This 
holds true in particular for specialised biotech firms and equipment and supplies 
companies. 
 
When assessing the overall effect of biotechnology on future employment, it is im-
portant to consider that the various jobs are influenced to different grades by bio-
technology. In order to take this aspect into account, we classified the total set of 
jobs affected by biotechnology into two clusters: a first cluster where biotechnology 
exerts a strong influence and a second cluster where the influence of biotechnology 
is restricted. 
 
In the first high impact cluster the number of jobs increases from about 220,000 in 
the year 2000 up to a range of 330,000 to 677,000 jobs in the year 2010, depending 
on diffusion rates and supply of university graduates. Hence, in the year 2010 a 
maximum of approximately 1.7 % of all employees in Germany are depending on 
biotechnology. In addition, spill-over effects of biotechnology on further jobs need 
to be considered. The upper limit of these jobs is given by the low impact biotech-
nology cluster. In particular the food industry and related upstream industries con-
tribute a large share to these jobs. The total number of jobs in this cluster increases 
from about 393,000 in the year 2000 to between 657,000 and more than 1 million 
people in the year 2010, depending on diffusion rates. 
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Figure 5: Development of employment until 2010 in those segments in which bio-








































































In all three scenarios the extent of the future employment effects of biotechnology 
depends crucially on the diffusion rates of biotechnology into additional application 
areas. Therefore, the absorption capabilities of the affected industries can be con-
sidered as a crucial factor for the further diffusion of biotechnology. In addition, the 
present and future impacts of biotechnology on various different industrial sectors 
indicate that biotechnology has taken root as an important key technology with a 
pronounced cross-sectional character. 
 
Quite frequently only a limited number of large firms in the industrial sectors af-
fected by biotechnology have at their command the required preconditions to inte-
grate complex technologies such as biotechnology into existing processes or to de-
velop new products and services based on biotechnology. However, most small and 14 
 
medium-sized enterprises in the various sectors affected by biotechnology do not 
possess the required skills. Since these small and medium enterprises provide an 
important contribution to the overall employment, it becomes crucial to develop the 
required interface competencies in these companies. This includes the creation of 
external knowledge and competence networks as well as entering strategic partner-
ships. 
 
The stimulation of knowledge generation in biotechnology should not be the only 
target of national and international policy initiatives but politics additionally should 
aim to support the further development of the knowledge base in the companies of 
the application industries of modern biotechnology which are responsible for a ma-
jor part of the employment effects of biotechnology. 
 
While no general lack of university graduates will limit the growth of industrial 
branches influenced by modern biotechnology until the year 2010, it cannot be ig-
nored that currently there are already some bottlenecks in specific niches (e. g. in 
bioinformatics) and that there will be increasing shortage in particular of specialised 
natural scientists and engineers in the future. In addition, industry complains about 
the low availability of experienced managers for biotechnology companies. A fur-
ther restriction might arise in the future in technical personnel for biotechnology 
whose labour market was not analysed in detail in the frame of this study. 
 
The supply of university graduates only can be extended by increasing the transition 
rates to universities and technical colleges or by shortening the length of the studies. 
Since these activities relatively fast will meet their limitations stronger emphasis 
has to be put on re-qualifying of employees in those fields which will be penetrated 
by modern biotechnology in the future. For this purpose corresponding opportuni-
ties for further training have to be established in order to maintain competitiveness 
and employment possibilities in the influenced companies and industrial branches. 
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Based on the results of this study a need for additional investigations could be iden-
tified. The expected results would also contribute to the fine adjustment of the re-
search design used for this project: 
  Identification of constraints for the diffusion of biotechnology in further applica-
tion sectors 
  Development of strategies to remove those obstacles 
  Improvement of the rather low knowledge on those factors that determine deci-
sions about human resources at a company level and the effect of those decisions 
on company development 
  Analysis of the present and future demand and supply of professions with a tech-
nical qualification for biotechnology 
  Enhancement of the quality and availability of statistical data on biotechnology: 
in order to monitor the further development of this area and to be able to shape 
the future evolution, it seems to be advisable to implement a continuous report-
ing scheme 
  Analysis of the relation between increased productivity due to biotechnology and 
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